NSE has issued a No Objection; BSE has no adverse observations for the draft scheme involving India Glycols, Ennature Biopharma, and IGL Spirits, paving the way for NCLT approval steps.
AI Assistant
India Glycols Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.